YD Bio Ltd YDES
5.20 USD +0.47 (+9.94%)
As ofNov 18, 2026, 1:26 PM EST
4.80 Day range 5.27
1.70 52-week range 15.72
- YTD
- -57.34%
- 1 year
- -46.78%
News
benzinga.com YD Bio Says FDA Agrees To Provide Written Guidance By January 4, 2027, To Support Development Of YDB-LMSCEV-001 YD Bio Limited ("YD Bio" or the "Company") (NASDAQ:YDES), a biotechnology company advancing DNA methylation-based cancer detection and ophthalmologic innovations, today announced that the U.S. Food…
globenewswire.com YD Bio Announces FDA Grant of INTERACT Meeting Request for YDB-LMSCEV-001, an Investigational Extracellular Vesicle Candidate for Dry Eye Disease FDA agrees to provide written guidance by January 4, 2027, to support development of YDB-LMSCEV-001 TAIPEI, Taiwan, Nov. 12, 2026 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio” or the “Company”)…
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session Gainers Milestone Scientific (AMEX:MLSS) stock moved upwards by 19.5% to $0.36 during Friday's pre-market session. The company's market cap stands at $27.1 million. Eton Pharmaceuticals (NASDAQ:ETON)…
benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session Gainers Profusa (NASDAQ:PFSA) shares moved upwards by 35.4% to $1.15 during Thursday's regular session. Karyopharm Therapeutics (NASDAQ:KPTI) shares increased by 29.12% to $0.55. The company's market…
